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ABSTRACT
Background: Diabetes mellitus (DM) is a common complication found in
β-thalassemia patients. The mechanism of DM in β-thalassemia patients is still
unclear, but it could be from an iron overload and increase of some cytokines, such as
interleukin1-β (IL-1β) and tumor necrosis factor-a (TNF-a). The objective of this
study was to study the effect of interaction between ferric ammonium citrate (FAC)
and cytokines, IL-1β and TNF-a, on 1.1B4 human pancreatic β-cell line.
Methods: The effect of the combination of FAC and cytokines on cell viability
was studied by MTT assay. Insulin secretion was assessed by the enzyme-linked
immunosorbent assay (ELISA). The reactive oxygen species (ROS) and cell apoptosis
in normal and high glucose condition were determined by flow cytometer.
In addition, gene expression of apoptosis, antioxidant; glutathione peroxidase 1
(GPX1) and superoxide dismutase 2 (SOD2), and insulin secretory function were
studied by real-time polymerase chain reaction (Real-time PCR).
Results: The findings revealed that FAC exposure resulted in the decrease of cell
viability and insulin-release, and the induction of ROS and apoptosis in pancreatic
cells. Interestingly, a combination of FAC and cytokines had an additive effect on
SOD2 antioxidants’ genes expression and endoplasmic reticulum (ER) stress.
In addition, it reduced the insulin secretion genes expression; insulin (INS), glucose
kinase (GCK), protein convertase 1 (PSCK1), and protein convertase 2 (PSCK2).
Moreover, the highest ROS and the lowest insulin secretion were found in FAC
combined with IL-1β and TNF-a in the high-glucose condition of human pancreatic
beta cell, which could be involved in the mechanism of DM development in
β-thalassemia patients.
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INTRODUCTION
One of the hereditary blood disorders resulting from a defect in β-globin chain synthesis
is β-thalassemia, which is caused by point mutation or, more rarely, deletion of the
β-globin gene (Galanello & Origa, 2010). These defects cause an imbalance between a and
β-globin chains leading to ineffective erythropoiesis (IE) chronic hemolytic anemia.
Extramedullary erythropoiesis is caused by β-thalassemia, which leads to bone deformities
and hepatosplenomegaly. Many complications were found such as heart failure, cirrhosis,
and endocrine complications including diabetes mellitus (DM) (Weatherall, 2003).
The prevalence of DM has been reported by up to 40% in β-thalassemia patients
(Ghergherehchi & Habibzadeh, 2015; Li et al., 2014; Liang et al., 2017; Metwalley &
El-Saied, 2014).
Patients with β-thalassemia and DM have a higher risk of cardiovascular complications
(Pepe et al., 2013). However, the mechanism of DM in β-thalassemia patients is still
unclear. Several mechanisms involved in DM development in β-thalassemia patients
were reported including insulin resistance, hepatic dysfunction, and insulin deficiency
resulting from β-cell damage or apoptosis (Noetzli et al., 2012; Ghergherehchi &
Habibzadeh, 2015; Li et al., 2014). However, there is no report linking iron and those
mechanisms in β-thalassemia patients.
Pancreatic β-cell damage is caused by many factors such as hyperglycemia, ROS,
pharmacological factors, environmental toxicity factors, tumors, chronic pancreatitis,
infections, inflammation, and autoimmunity. ROS caused by iron leads to damaged cells
via the Fenton reaction. Iron is thought to cause cell death through ROS-dependent and
-independent mechanisms (Dixon & Stockwell, 2014; Bogdan et al., 2016). Although
the iron metabolism in pancreatic β-cells is still unclear, it is believed that pancreatic islet
cells are susceptible to oxidative damage because they express low levels of antioxidants
(Tiedge et al., 1997). One study of iron regulation in pancreatic islet cells reported that
high expression of divalent metal transporter (DMT1) caused more iron deposits in
pancreatic cells than other cells (Andrews, 1999).
In β-thalassemia patients, iron might not be the only factor that causes β-cell
damage. Increased levels of inflammatory cytokines have been reported in β-thalassemia
patients, especially TNF-a and IL-1β with mean levels 3- and 28-times higher than normal
controls, respectively (Wanachiwanawin et al., 1999). These might cause β-cell damage
through apoptosis signaling pathways in β-thalassemia patients. In addition, cytokines,
especially IL-1β, also have the potential to increase intracellular iron and ROS, which cause
apoptosis as has been described in insulin-producing cells (Hansen et al., 2012). Therefore,
the increase of both iron and cytokines might be an important mechanism of DM in
β-thalassemia patients. Here, the combined effect of iron and cytokines on the human
pancreatic β-cell line is examined.
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MATERIALS AND METHODS
Pancreatic cell culture
The human pancreatic β-cell line 1.1B4 was generated by electrofusion of freshly
isolated human pancreatic beta cells and the human PANC-1 epithelial cell line. It showed
glucose sensitivity and responsiveness to known modulators of insulin secretion
(McCluskey et al., 2011). The 1.1B4 cells passage 28 (ECACC Cat. No. 10012801) were
routinely cultured in pre-warmed RPMI640 culture medium with L-glutamine containing
11.1 mM glucose (Thermo Fisher Scientific, Waltham, MA, USA) supplemented with
10% v/v fetal bovine serum (Merck, Burlington, MA, USA) and 10 U/ml penicillin and
0.1 g/l streptomycin (Thermo Fisher Scientific, Waltham, MA, USA) at 37 C in 5%CO2.
1.1B4 cell treatment with FAC, cytokines and high glucose
The 1.1B4 cells were plated on six well plates with or without high glucose condition
(22.2 mM glucose) (Vasu et al., 2013) and allowed to attach into cell plates for 24 h. Then,
they were treated with different concentrations of FAC (Merck) or IL-1β or TNF-a (Cell
Signaling Technology, Danvers, MA, USA) for 12 and 24 h.
Cell viability analysis by MTT assay
MTT assay (3-(4, 5-Dimethylthiazol-2-yl)-2, 5-Diphenyltetrazolium Bromide) (Thermo
Fisher Scientific, Waltham, MA, USA) was used to compare the effect of FAC, IL-1β,
and TNF-a on cell viability. The 1.1B4 cells were plated on 96 well plates and allowed to
attach plates for 24 h. After the treatment, the culture medium was removed, and 100 ml of
culture medium was added. Then, ten microliters of 12 mM MTT was added and
incubated for 4 h at 37 C. Finally, 85 µL MTT-containing medium and 50 µl DMSO was
added to each well and analyzed at 540 nm by a SpectraMax 200 (Molecular Device,
San Jose, CA, USA).
Analysis of intracellular ROS by flow cytometer
Intracellular ROS was detected by 2′,7′-Dichlorodihydrofluorescein diacetate (DCFH-DA)
(Merck, Kenilworth, NJ, USA); the cells were trypsinized and washed twice with Ca2+ and
Mg2+-free Dulbecco’s phosphate buffer saline, then transferred to polypropylene (PP)
tube. Then 0.05 mg/mL of DCFH-DA was added into the tube and incubated for 15 min at
37 C, 5% CO2. The fluorescence signal was detected by a fluorescence-activated cell
sorting (FACS) Canto flow cytometer (BD Biosciences, San Jose, CA, USA) and was
analyzed by FACSDiva software (BD Biosciences, San Jose, CA, USA).
Analysis of apoptotic cells by flow cytometer
The apoptosis cells were detected using Annexin V: FITC Apoptosis Detection Kit I (BD
Biosciences, San Jose, CA, USA). The cells were washed and incubated with fluorescein
isothiocyanate (FITC) conjugated Annexin V (AnV) and propidium iodide (PI) at room
temperature for 15 min. Fluorescence was detected by a FACSCanto flow cytometer
and analyzed with FACSDiva software (BD Biosciences, San Jose, CA, USA).
Rattanaporn et al. (2020), PeerJ, DOI 10.7717/peerj.9298 3/14
Gene expression by RT-qPCR
Total RNA was extracted from 1.1B4 cells using TRIzol reagent (Invitrogen, Calsbad, MA,
USA). Then, the conversion of 5 µg of total RNA to cDNA using RevertAid kit (Thermo
Fisher Scientific, Waltham, MA, USA) following the manufacturer’s instructions, the
qPCR was performed using SYBR green. The Select Master Mix for CFX (Applied
Biosystem, Foster City, CA, USA) was used for RT-qPCR, through specific primers, and
run on CFX96 Touch Real-Time PCR (Bio-Rad, Hercules, CA, USA). The level of target
gene expression was normalized against ATCB expression. The mRNA fold change was
calculated using the 2−ΔΔCt method, with the values expressed as fold change relative to the
untreated control.
Insulin measurement by ELISA
The 1.1B4 cell was treated with FAC alone, cytokine (IL-1β or TNF-a alone), two
cytokines (IL-1β + TNF-a), FAC combined with each cytokine (FAC + IL-1β or TNF-a),
and FAC combined with both cytokines (FAC + IL-1β + TNF-a) for 24 h. Then, insulin
secretion was assayed by ELISA using the human insulin ELISA kit (Merck, Kenilworth,
NJ, USA), according to the manufacturer’s protocol.
Statistical analysis
The results were analyzed by one-way and two-way analysis of variance (ANOVA) and
presented in mean ± SEM of three independent experiments. The difference in results was
considered significant when p < 0.05.
RESULTS
FAC induce ROS production, reduce cell viability, and decrease insulin
expression of pancreatic β-cell
The accumulated iron in β-cell islets might promote ROS levels and cell apoptosis leading
to a decrease in insulin production. The cellular ROS levels and cytotoxic effects of
iron were first examined in pancreatic beta cells. FAC (0.1–15 mM) increased ROS levels
in a dose-dependent manner (p < 0.05) (Fig. 1A). In addition, FAC induced pancreatic
cell apoptosis and reduced cell viability in a dose- and time-dependent manner
(Figs. 1B–1C and 1G). The highest ROS (MFI 1,375 ± 64.26) and apoptosis (40%) were
found in 15 mM FAC-treated cells at 24 h (Figs. 1A and 1B). Expression of apoptotic
regulatory proteins include BAX, BCL2 and STAT1 were assessed to study the effect of
FAC on β-cell apoptosis. In the 1.1B4 cells treated with 8 mM FAC the BAX were
up-regulated at 12 h and down-regulated at 24 h while BCL2 was down-regulated at 12 and
24 h (Figs. 1D–1F). The lowest cell viability (40%, p < 0.001) was found in cells treated with
10 and 15 mM FAC for 24 h (Fig. 1G).
Insulin expression and secretion were assessed to study the effect of FAC on β-cell
function. In the 1.1B4 cells treated with 8 mM FAC the insulin (INS) expression and
insulin level decreased in a time-dependent manner (Figs. 1H and 1I).
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Figure 1 Iron-induce intracellular ROS generation, increase cell death, reduce INS expression, and
insulin production in pancreatic β-cells. The 1.1B4 cells were exposed to different concentrations of
FAC for 12 and 24 h. (A) ROS, cells stained with DCFH-DA were detected using a flow cytometer.
(B) Apoptosis, cells were stained with fluorescein isothiocyanate (FITC)-conjugated Annexin V and PI and
was detected by using a flow cytometer. (C) Flow plots of apoptosis. Apoptosis regulatory gene expression,
mRNA were extracted and converted to cDNA. The mRNA expression was normalized to ACTB
expression; (D) BAX expression. (E) BCL2 expression. (F) STAT1: expression. (G) cell viability was mea-
sured using MTT assay. The INS expression was checked, and the cultured medium was collected for
insulin measurement using an ELISA kit. (H) INS expression in 2−ΔΔCt. Later, it was normalized by ACTB.
(I) insulin level, which was normalized by the untreated cells. The results were shown in mean ± SEM from
three independent experiments and yielded. p < 0.05 and  p < 0.001 indicate a statistically difference
compared to the untreated cells. p < 0.0001, indicating a statistically significant difference compared with
untreated cells and 12 h using a one-way ANOVA test. Full-size DOI: 10.7717/peerj.9298/fig-1
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Combination of FAC and cytokines induce ROS production, apoptosis,
and reduces insulin expression of pancreatic β-cells
Cytokine activates the production of ROS and reduction of insulin secretion which lead
to diabetes. The effect of FAC combined with cytokines on pancreatic β-cells was
observed. Cells were treated with IL-1β alone, TNF-a alone, IL-1β combined with
TNF-a, FAC alone, and FAC combined with IL-1β, FAC combined with TNF-a, and
FAC combined with IL-1β and TNF-a for 24 h. The results showed that ROS and
percentage of apoptosis increased but had not significantly different compared between
FAC with cytokines and FAC alone (Figs. 2A and 2B). Insulin secretion and INS
expression was reduced in FAC combined with IL-1β or TNF-a compared with FAC
alone (Figs. 2C and 2D).
The effect of 22.2 mM high glucose was also investigated in 1.1B4 cells, cell viability
of pancreatic cell treated with cytokines with FAC was lower than in a normal glucose
condition. The lowest cell viability was found in FAC combined with IL-1β and TNF-a in
a high-glucose condition (Fig. 3A). In addition, the highest ROS was found in FAC
combined with IL-1β and TNF-a in the high-glucose condition (Fig. 3B). Apoptosis of
pancreatic cells in the high-glucose condition was higher than in the normal glucose
condition. Interestingly, the highest apoptosis (Fig. 3C), lowest insulin secretion (Fig. 3D)
and lowest INS expression were found in FAC combined with IL-1β and TNF-a in the
high-glucose condition (Fig. 3E).
FAC combined with IL-1β and TNF-α decrease secretory function
genes through antioxidant defense, apoptosis, and ER stress
From these results showed that iron (FAC) and cytokines reduce insulin secretion capacity,
this evidence was examined by measuring the expression of genes involved in antioxidant
defense, apoptosis pathways, ER stress, and secretory function (Fig. 4). Two important
antioxidant genes in the pancreas, including superoxide dismutase 2 (SOD2) and
glutathione peroxidase 1 (GPX.1) were measured. The results showed that the highest
SOD2 expression was found in FAC combined with TNF-a alone and FAC combined with
IL-1β and TNF-a (Fig. 4A). In addition, apoptosis-related genes, including B-cell
lymphoma 2 (BCL2), Nuclear factor-κB (NFκB), and signal transducer and activator of
transcription 1 (STAT1) were studied. The results showed that the expression of BCL2,
NFκB, and STAT1 was decreased (Figs. 4C–4E). Gene expressions of Heat Shock
Protein Family A (Hsp70) Member 4 (HSPA4) and Heat Shock Protein Family A
(Hsp70) Member 5 (HSPSA5), ER stress marker genes, were analyzed. The highest
gene expression ofHSPA4 was shown in FAC combined with both cytokines. However, the
gene expression of HSPA5 was decreased (Figs. 4F and 4G). Moreover, insulin-secretion
related genes including glucose kinase (GCK), proprotein convertase subtilisin/kexin
type 1 (PCSK1), and proprotein convertase subtilisin/kexin type 2 (PCSK2) were
determined. The expressions of these genes were decreased more than two times in FAC
treated alone and in combination with cytokines (Figs. 4H–4J).
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DISCUSSION
DM is commonly found in β-thalassemia patients. The overload of iron and increased of
cytokines may affect the β-cell function and insulin secretion capacity, which lead to DM
(Wanachiwanawin et al., 1999). However, the mechanism of DM in thalassemia is still
unclear. The purpose of this research is to study the effect of FAC combined with cytokines
IL-1β and TNF-a on 1.1B4 in the human pancreatic islet cell line.
Firstly, we found that iron exposure resulted in a reduction of cell viability, induction of
ROS, and increasing of apoptosis in a dose-dependent manner in 1.1B4 cells that have been
previously reported in other types of cell line such as HH4, human hematopoietic
cells/mesenchymal cells, MC3T3-E1 cells, and MG-63 cells through different mechanisms
(Li et al., 2016; Lu et al., 2013; Doyard et al., 2012; Yang et al., 2017; Ke et al., 2017). Many
reports have been demonstrated that iron overload lead to increasing intracellular ROS
and caused cell damage, which is concomitant with our results. Moreover, our results
showed the reduction of INS expression and insulin secretion that might be affected by
Figure 2 The effect of FAC combine with IL-1β and TNF-a. The 1.1B4 cells were treated with 8 mM
FAC combined with 10 pg/mL of IL-1β, FAC combined with 20 pg/mL of TNF-a, and FAC combined
with IL-1β and TNF-a for 24 h. (A) ROS cells stained with DCFH-DA were detected using a flow
cytometer. (B) Apoptosis cells stained with fluorescein isothiocyanate (FITC)-conjugated AnV and PI
were detected using a flow cytometer. (C) INS expression, mRNA were extracted and converted to cDNA.
The mRNA expression was normalized to ACTB expression. (D) Insulin level. The culture medium was
collected for insulin measurement using the ELISA technique. The results are shown in mean ± SEM
from three independent experiments and yield a p < 0.0001, indicating a statistically significant dif-
ference compared with the untreated cells and a p < 0.05, indicating a statistically significant difference
compared with FAC treated alone. Full-size DOI: 10.7717/peerj.9298/fig-2
Rattanaporn et al. (2020), PeerJ, DOI 10.7717/peerj.9298 7/14
Figure 3 The effect of high glucose on iron combined with IL-1β- and TNF-a-treated cells. The 1.1B4
cells were treated with 8 mM FAC combined with 10 pg/mL of IL-1β, FAC combined with 20 pg/mL of
TNF-a, and FAC combined with IL-1β and TNF-a in no adding glucose and 22.2 mM glucose adding
condition for 24 h. (A) Cell count, the cells stained with typhan blue were counted under a microscope.
(B) The ROS, cells stained with DCFH-DA were detected using a flow cytometer. (C) The apoptosis cells
stained with fluorescein isothiocyanate (FITC)-conjugated AnV and PI were detected using a flow cyt-
ometer. (D) Insulin level, the culture medium was collected for insulin measurement using the ELISA
technique. (E) INS expression, mRNA were extracted and converted to cDNA. The mRNA expression
was shown as delta Ct values calculated from CtINS to CtACTB. The results are shown in mean ± SEM of
three independent experiments and revealed a p < 0.01 and a p < 0.0001, indicating the statistically
significant differences compared to the no adding glucose. represent the significantly difference at
p < 0.05. Full-size DOI: 10.7717/peerj.9298/fig-3
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Figure 4 The expression of genes involved in insulin secretion, antioxidants, ER stress, and apoptosis signaling pathways. Following FAC and
cytokines exposure, mRNA was extracted and converted to cDNA. The mRNA expression was normalized to ACTB expression. The results are
shown as mean ± SEM of three independent experiments and indicated a p < 0.05, p < 0.01, and p < 0.0001, indicating the statistically
significant differences compared to the untreated cells. The antioxidant genes include SOD2 (A) and GPX.1 (B). The apoptosis pathway genes are
BCL2 (C), NFκB (D), and STAT1 (E). ER stress genes include HSPA4 (F) and HSPA5 (G). The secretory function genes include GCK (H), PSCK1 (I),
and PSCK2 (J). Full-size DOI: 10.7717/peerj.9298/fig-4
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ROS induced by FAC, which finally cause β-cell damage. FAC was previously used to
induce the excess intracellular iron and caused increasing of ROS affected insulin secretion
in Rat insulinoma pancreatic β-cells (RINm5F) as a model of pancreatic iron overload in
β-thalassemia patients (Koonyosying et al., 2019).
The toxic effects of cytokines was studied but the mechanism or pathway underlying
those effects in pancreatic β-cell is still unclear. Numerous studies whose findings
reported that short-term treatment with cytokines such as IL-1β, TNF-a, and interferon γ
(IFN-γ), alone or in combination could induce apoptosis of islet cells and dysfunction of
pancreatic β-cells to release insulin (Vasu et al., 2014; Wang, Guan & Yang, 2010), are
concomitant with our results.
Interestingly, β-thalassemia patients with iron overloading had high levels of these
cytokines and high percentage of apoptosis. The iron and cytokines-induced apoptosis might
be the cause of β-cell dysfunction and DM development in these patients. From our
results, FAC combined with IL-1β and TNF-a had an additive effect on reducing INS
expression, inducing SOD2 antioxidants’ genes expression and activating endoplasmic
reticulum (ER) stress. The increasing of ROS in FAC combined with IL-1β and TNF-a
induced the expression of antioxidant SOD2 have been reported (Wang et al., 2018).
In addition, the induction of SOD2 expression by cytokines was reported (Vasu et al., 2014).
Moreover, the result revealed that the HSPA4 heat shock 70 kDa protein 4 genes responded
to the activation of oxidative stress, protein-folding, and secretion demands that can be
found in hyperglycemia (Berchtold et al., 2016). Jacob and co-workers found that 100 pg/ml
of IL-1β induced divalent metal transporter 1 (DMT1) expression and caused increasing of
ROS and activating apoptosis pathway in pancreatic islets cells (Hansen et al., 2012).
This information is not consistent with our results that ROS and apoptosis in FAC combined
with IL-1β and/or TNF-a were not significantly different from FAC treated alone.
Iron-induced ROS can activate ferroptosis which might be the possible mechanism
of pancreatic β-cell damage in our study. It is a non-apoptosis cell death is induced by
the small molecule or condition that inhibits glutathione biosynthesis or the cellular
glutathione-dependent antioxidant enzyme glutathione peroxidase 4 (GPX4) and results
in an accumulation of ROS (Cao & Dixon, 2016; Xie et al., 2016).
Experiments conducted with high glucose concentrations shows significant apoptotic
death compared to normal medium in untreated cells however no change in cell
count and ROS, because high glucose could activate apoptosis signaling pathway and
down-regulation of anti-apoptotic proteins BCL2, MAPK8, and MAPK10 (Vasu et al.,
2013). However, only high glucose had less affect to cell count and level of ROS but when
combine high glucose with FAC, and cytokines could lead to increase level of ROS.
Hyperglycemic condition in the combination of FAC and cytokines induce production of
ROS and lead to apoptosis and cause reducing of insulin in 1.1B4 cells that might be
resulting from the down regulation of INS and other genes involved in insulin secretion,
including GCK, PSCK1, and PSCK2 (Vasu et al., 2014; Kooptiwut et al., 2005; Jonas et al.,
2009; Laybutt et al., 2002). This might be due to the interference of high glucose that
reduces the PDX1, an important gene involved in the secretory function (Sachdeva et al.,
2009). The effect of cytokines on insulin production in hyperglycemia was found
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(Zhang & Kim, 1995; Kiely et al., 2007). Moreover, it was found that glucose toxicity
induced ROS production and activated the apoptosis signaling pathway (Robertson, 2004).
This information is concomitant with our study that the highest ROS, the lowest INS
expression, and insulin secretion were found in FAC combined with IL-1β and TNF-a in
high glucose level. This results could be supported the mechanism of insulin dependent or
DM development in β-thalassemia patients who had iron overload and high level of
cytokines IL-1β or TNF-a.
However, this study was performed only in human pancreatic β-cell line as a model
which no direct measurement in humans and external validation but our previous data
suggests that in β-thalassemia/HbE patients with diabetes had high level of ROS, low
level of glutathione, reduced the β-cell function (HOMAB) and insulin level decreased
(P. Rattanaporn, 2019, unpublished data).
CONCLUSIONS
This study suggests that FAC combined with cytokines, IL-1β and TNF-a in high glucose
condition could increase ROS production, ER stress and apoptosis induction. However,
they reduce insulin secretion in human pancreatic β-cell lines. This information could be
benefit for understanding the mechanism on development of DM in thalassemia patient.
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